Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lung Neoplasms 1 Hematologic Neoplasms 1

Interventions

Cyclophosphamide 17 fludarabine 16 fludarabine phosphate 11 venetoclax 9 Azacitidine 9 Rituximab 8 Nivolumab 7 Melphalan 7 Tacrolimus 6 Cytarabine 6 Specimen Handling 5 Sirolimus 5 Ipilimumab 5 Clofarabine 5 CTLA-4 Antigen 5 Antilymphocyte Serum 5 belinostat 4 aldesleukin 4 Thiotepa 4 Standard of Care 4 Practice Guidelines as Topic 4 Mycophenolic Acid 4 Methotrexate 4 Magnetic Resonance Spectroscopy 4 Interleukin-2 4 Granulocyte Colony-Stimulating Factor 4 Dexamethasone 4 Busulfan 4 Bortezomib 4 Bevacizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Hematologic Neoplasms × monalizumab × Clear all

NCT02921685 2018-09-19

PIRAT

Institut Paoli-Calmettes

Phase 1 Unknown

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡